 Shares of Seagen Inc. SGEN, 12.02 shot up 14.7 toward a seven-month high in morning trading Friday, after The Wall Street Journal reported that Merck Co. Inc. MRK, -0.02 is looking into buying the cancer-focused biotechnology company. Meanwhile, drug-maker Mercks stock eased 0.2. 